Literature DB >> 17263130

Stem cell transplant for first relapse from the multiple myeloma research foundation.

Kenneth C Anderson1, David H Vesole.   

Abstract

Treatment regimens for multiple myeloma are evolving because of new advances in both pharmacotherapy and transplantation strategies. The Multiple Myeloma Research Foundation (MMRF) has gathered the top thought leaders in myeloma research to prepare an engaging interactive series of case studies in multiple myeloma, which are available online at www.multiplemyeloma.org and will be published on a regular basis in ONCOLOGY. For more information about the interactive series, see the MMRF ad on page 1881.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17263130

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  1 in total

1.  Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myeloma.

Authors:  Tomer Mark; Jessica Stern; Jessica R Furst; David Jayabalan; Faiza Zafar; April LaRow; Roger N Pearse; John Harpel; Tsiporah Shore; Michael W Schuster; John P Leonard; Paul J Christos; Morton Coleman; Ruben Niesvizky
Journal:  Biol Blood Marrow Transplant       Date:  2008-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.